Status:
COMPLETED
Molecular Screening for Lynch Syndrome in Denmark
Lead Sponsor:
Vejle Hospital
Conditions:
Colorectal Cancer
Lynch Syndrome
Eligibility:
All Genders
Brief Summary
A clinically applicably strategy for molecular screening for Lynch Syndrome is being implemented in Denmark. Based on sequential analysis with immunohistochemistry and methylation analysis, patients ...
Eligibility Criteria
Inclusion
- Histological diagnosis of colorectal adenocarcinoma
- Diagnosed at one of the departments of pathology in Denmark
Exclusion
- None
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT01845753
Start Date
October 1 2012
End Date
December 31 2019
Last Update
January 23 2020
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pathology
Aalborg, Denmark
2
Department of Clinical Genetics
Aarhus, Denmark
3
Department of Pathology
Aarhus, Denmark
4
Department of Pathology
Esbjerg, Denmark